Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies

Redox Biology

Volumn 2, Issue 1, 2014, Pages 619-631

  Wilkins, Heather M ^a   Carl, Steven M ^a   Swerdlow, Russell H ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Cybrid; Mitochondria; Mitochondrial DNA; Rho zero

Indexed keywords

MITOCHONDRIAL DNA; CELL NUCLEUS DNA;

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CELL LINE; CYBRID; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA TRANSFER; GENETIC COMPATIBILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUNTINGTON CHOREA; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRIAL GENETICS; MUTATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; RHO ZERO CELL; CELL HYBRIDIZATION; HAPLOTYPE; HYBRIDOMA CELL LINE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATION REDUCTION STATE; PHENOTYPE; BIOLOGICAL MODEL; CELL FUSION; GENETICS; METABOLISM; MITOCHONDRION; PATHOLOGY;

CELL FUSION; CELL LINE; DNA, MITOCHONDRIAL; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MODELS, BIOLOGICAL;

EID: 84897982930     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2014.03.006     Document Type: Review

References (166)

1. Nass M.M., Nass S. Intramitochondrial fibers with DNA characteristics. I. Fixation and electron staining reactions. Journal of Cell Biology 1963, 19:593-611. http://www.ncbi.nlm.nih.gov/pubmed/14086138, 10.1083/jcb.19.3.593.
2. Nass S., Nass M.M. Intramitochondrial fibers with DNA characteristics. II. Enzymatic and other hydrolytic treatments. Journal of Cell Biology 1963, 19:613-629. http://www.ncbi.nlm.nih.gov/pubmed/14086139, 10.1083/jcb.19.3.613.
3. Lin M.T., Simon D.K., Ahn C.H., Kim L.M., Beal M.F. High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Human Molecular Genetics 2002, 11:133-145. 38. http://www.ncbi.nlm.nih.gov/pubmed/11809722, 10.1093/hmg/11.2.133.
4. Larsson N.G. Somatic mitochondrial DNA mutations in mammalian aging. Annual Review of Biochemistry 2010, 79:683-706. http://www.ncbi.nlm.nih.gov/pubmed/20350166, 10.1146/annurev-biochem-060408-093701.
5. Bratic A., Larsson N.G. The role of mitochondria in aging. Journal of Clinical Investigation 2013, 123:951-957. http://www.ncbi.nlm.nih.gov/pubmed/23454757, 10.1172/JCI64125.
6. Ephrussi B., Hottinger H., Chimenes A.M. Action de l'acriflavine sur les levures, I: la mutation "petite clonie.". Annales de l'Institut Pasteur (Paris) 1949, 76:531.
7. Slonimski P.P., Perrodin G., Croft J.H. Ethidium bromide induced mutation of yeast mitochondria: complete transformation of cells into respiratory deficient non-chromosomal "petites". Biochemical and Biophysical Research Communications 1968, 30:232-239. http://www.ncbi.nlm.nih.gov/pubmed/5647224, 10.1016/0006-291X(68)90440-3.
8. Goldring E.S., Grossman L.I., Krupnick D., Cryer D.R., Marmur J. The petite mutation in yeast. Loss of mitochondrial deoxyribonucleic acid during induction of petites with ethidium bromide. Journal of Molecular Biology 1970, 52:323-335. http://www.ncbi.nlm.nih.gov/pubmed/5485912, 10.1016/0022-2836(70)90033-1.
9. Nagley, Linnane W. Mitochondrial DNA deficient petite mutants of yeast 1970, 39:989-996. http://www.ncbi.nlm.nih.gov/pubmed/5423835, 10.1016/0006-291X(70)90422-5.
10. Wiseman A., Attardi G. Reversible tenfold reduction in mitochondria DNA content of human cells treated with ethidium bromide. Molecular & General Genetics 1978, 167:51-63. http://www.ncbi.nlm.nih.gov/pubmed/739978.
11. Desjardins P., Frost E., Morais R. Ethidium bromide-induced loss of mitochondrial DNA from primary chicken embryo fibroblasts. Molecular and Cellular Biology 1985, 5:1163-1169. http://www.ncbi.nlm.nih.gov/pubmed/2987677.
12. Gregoire M., Morais R., Quilliam M.A., Gravel D. On auxotrophy for pyrimidines of respiration-deficient chick embryo cells. European Journal of Biochemistry / FEBS 1984, 142:49-55. http://www.ncbi.nlm.nih.gov/pubmed/6086342, 10.1111/j.1432-1033.1984.tb08249.x.
13. Desjardins P., de Muys J.M., Morais R. An established avian fibroblast cell line without mitochondrial DNA. Somatic Cell and Molecular Genetics 1986, 12:133-139. http://www.ncbi.nlm.nih.gov/pubmed/3008349, 10.1007/BF01560660.
14. Morais R., Desjardins P., Turmel C., Zinkewich-Peotti K. Development and characterization of continuous avian cell lines depleted of mitochondrial DNA. In Vitro Cellular & Developmental Biology: Journal of the Tissue Culture Association 1988, 24:649-658. http://www.ncbi.nlm.nih.gov/pubmed/2840430, 10.1007/BF02623602.
15. Swerdlow R.H., Parks J.K., Miller S.W., Tuttle J.B., Trimmer P.A., Sheehan J.P., Bennett J.P., Davis R.E., Parker W.D. Origin and functional consequences of the complex I defect in Parkinson's disease. Annals of Neurology 1996, 40:663-671. http://www.ncbi.nlm.nih.gov/pubmed/8871587, 10.1002/ana.410400417.
16. King M.P., Attardi G. Human cells lacking mtDNA: Repopulation with exogenous mitochondria by complementation. Science 1989, 246:500-503. http://www.ncbi.nlm.nih.gov/pubmed/2814477, 10.1126/science.2814477.
17. King M.P., Attardi G. Isolation of human cell lines lacking mitochondrial DNA. Methods in Enzymology 1996, 264:304-313. http://www.ncbi.nlm.nih.gov/pubmed/8965704, 10.1016/S0076-6879(96)64029-4.
18. Hayashi J., Ohta S., Kikuchi A., Takemitsu M., Goto Y., Nonaka I. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:10614-10618. http://www.ncbi.nlm.nih.gov/pubmed/1720544, 10.1073/pnas.88.23.10614.
19. Bodnar A.G., Cooper J.M., Holt I.J., Leonard J.V., Schapira A.H. Nuclear complementation restores mtDNA levels in cultured cells from a patient with mtDNA depletion. American Journal of Human Genetics 1993, 53:663-669. http://www.ncbi.nlm.nih.gov/pubmed/8394647.
20. Suissa S., Wang Z., Poole J., Wittkopp S., Feder J., Shutt T.E., Wallace D.C., Shadel G.S., Mishmar D. Ancient mtDNA genetic variants modulate mtDNA transcription and replication. PLoS Genetics 2009, 5:e1000474. http://www.ncbi.nlm.nih.gov/pubmed/19424428, 10.1371/journal.pgen.1000474.
21. Jun A.S., Trounce I.A., Brown M.D., Shoffner J.M., Wallace D.C. Use of transmitochondrial cybrids to assign a complex I defect to the mitochondrial DNA-encoded NADH dehydrogenase subunit 6 gene mutation at nucleotide pair 14459 that causes Leber hereditary optic neuropathy and dystonia. Molecular and Cellular Biology 1996, 16:771-777. http://www.ncbi.nlm.nih.gov/pubmed/8622678.
22. Miller S.W., Trimmer P.A., Parker W.D., Davis R.E. Creation and characterization of mitochondrial DNA-depleted cell lines with "neuronal-like" properties. Journal of Neurochemistry 1996, 67:1897-1907. http://www.ncbi.nlm.nih.gov/pubmed/8863494.
23. Swerdlow R.H., Parks J.K., Cassarino D.S., Maguire D.J., Maguire R.S., Bennett J.P., Davis R.E., Parker W.D. Cybrids in Alzheimer's disease: acellular model of the disease?. Neurology 1997, 49:918-925. http://www.ncbi.nlm.nih.gov/pubmed/9339668, 10.1212/WNL.49.4.918.
24. Binder D.R., Dunn W.H., Swerdlow R.H. Molecular characterization of mtDNA depleted and repleted NT2 cell lines. Mitochondrion 2005, 5:255-265. http://www.ncbi.nlm.nih.gov/pubmed/16050988, 10.1016/j.mito.2005.04.003.
25. Swerdlow R.H., Redpath G.T., Binder D.S., Davis J.N., VandenBerg S.R. Mitochondrial DNA depletion analysis by pseudogene ratioing. Journal of Neuroscience Methods 2006, 150:265-271. http://www.ncbi.nlm.nih.gov/pubmed/16118020, 10.1016/j.jneumeth.2005.06.023.
26. Malik S., Sudoyo H., Pramoonjago P., Suryadi H., Sukarna T., Njunting M., Sahiratmadja E., Marzuki S. Nuclear mitochondrial interplay in the modulation of the homopolymeric tract length heteroplasmy in the control (D-loop) region of the mitochondrial DNA. Human Genetics 2002, 110:402-411. http://www.ncbi.nlm.nih.gov/pubmed/12073009, 10.1007/s00439-002-0717-3.
27. Li H., Kumar Sharma L., Li Y., Hu P., Idowu A., Liu D., Lu J., Bai Y. Comparative bioenergetic study of neuronal and muscle mitochondria during aging. Free Radical Biology and Medicine 2013, 63:30-40. http://www.ncbi.nlm.nih.gov/pubmed/23643721, 10.1016/j.freeradbiomed.2013.04.030.
28. Olszanski A.J., LaCroix-Fralish M.L., Armand R., Perez P., Lewis L.D. Molt-4 Rho(0) cells up regulated stress-induced survival genes in an attempt to overcome the potentially lethal consequence of mitochondrial DNA depletion. Clinical Pharmacology and Therapeutics 2004, 75(2):1-142.
29. Inoue K., Takai D., Hosakia H., Ito S., Shitara H., Isobe K., LePecq J.B., Segal-Bendirdjian E., Hayashi J. Isolation and characterization of mitochondrial DNA-less lines from various mammalian cell lines by application of an anticancer drug, ditercalinium. Biochemical and Biophysical Research Communications 1997, 239:257-260. http://www.ncbi.nlm.nih.gov/pubmed/9345305.
30. Jazayeri M., Andreyev A., Will Y., Ward M., Anderson C.M., Clevenger W. Inducible expression of a dominant negative DNA polymerase-gamma depletes mitochondrial DNA and produces a rho0 phenotype. Journal of Biological Chemistry 2003, 278:9823-9830. http://www.ncbi.nlm.nih.gov/pubmed/12645575, 10.1074/jbc.M211730200.
31. Nelson I., Hanna M.G., Wood N.W., Harding A.E. Depletion of mitochondrial DNA by ddC in untransformed human cell lines. Somatic Cell and Molecular Genetics 1997, 23:287-290. http://www.ncbi.nlm.nih.gov/pubmed/9542530, 10.1007/BF02674419.
32. Ashley N., Harris D., Poulton J. Detection of mitochondrial DNA depletion in living human cells using pico green staining. Experimental Cell Research 2005, 303:432-446. http://www.ncbi.nlm.nih.gov/pubmed/15652355, 10.1016/j.yexcr.2004.10.013.
33. Gear A.R. Rhodamine 6G. A potent inhibitor of mitochondrial oxidative phosphorylation. Journal of Biological Chemistry 1974, 249:3628-3637. http://www.ncbi.nlm.nih.gov/pubmed/4275428.
34. Williams A.J., Murrell M., Brammah S., Minchenko J., Christodoulou J. A novel system for assigning the mode of inheritance in mitochondrial disorders using cybrids and rhodamine 6G. Human Molecular Genetics 1999, 8:1691-1697. http://www.ncbi.nlm.nih.gov/pubmed/10441332, 10.1093/hmg/8.9.1691.
35. Wong A., Cavelier L., Collins-Schramm H.E., Seldin M.F., McGrogan M., Savontaus M.L., Cortopassi G.A. Differentiation-specific effects of LHON mutations introduced into neuronal NT2 cells. Human Molecular Genetics 2002, 11:431-438. http://www.ncbi.nlm.nih.gov/pubmed/11854175, 10.1093/hmg/11.4.431.
36. Kukat A., Kukat C., Brocher J., Schäfer I., Krohne G., Trounce I.A., Villani G., Seibel P. Generation of rho0 cells utilizing a mitochondrially targeted restriction endonuclease and comparative analyses. Nucleic Acids Research 2008, 36:e44. http://www.ncbi.nlm.nih.gov/pubmed/18353857, 10.1093/nar/gkn124.
37. Heller S., Schubert S., Krehan M., Schäfer I., Seibel M., Latorre D., Villani G., Seibel P. Efficient repopulation of genetically derived rho zero cells with exogenous mitochondria. PLOS One 2013, 8:e73207. http://www.ncbi.nlm.nih.gov/pubmed/24019909, 10.1371/journal.pone.0073207.
38. Poste G., Reeve P. Enucleation of mammalian cells by cytochalasin B. II. Formation of hybrid cells and heterokaryons by fusion of anucleate and nucleated cells. Experimental Cell Research 1972, 73:287-294. http://www.ncbi.nlm.nih.gov/pubmed/4341004, 10.1016/0014-4827(72)90050-X.
39. Bunn C.L., Wallace D.C., Eisenstadt J.M. Cytoplasmic inheritance of chloramphenicol resistance in mouse tissue culture cells. Proceedings of the National Academy of Sciences of the United States of America 1974, 71:1681-1685. http://www.ncbi.nlm.nih.gov/pubmed/4525288, 10.1073/pnas.71.5.1681.
40. Wallace D.C., Bunn C.L., Eisenstadt J.M. Cytoplasmic transfer of chloramphenicol resistance in human tissue culture cells. Journal of Cell Biology 1975, 67:174-188. http://www.ncbi.nlm.nih.gov/pubmed/1176530, 10.1083/jcb.67.1.174.
41. Chomyn A., Lai S.T., Shakeley R., Bresolin N., Scarlato G., Attardi G. Platelet-mediated transformation of mtDNA-less human cells: analysis of phenotypic variability among clones from normal individuals-and complementation behavior of the tRNALys mutation causing myoclonic epilepsy and ragged red fibers. American Journal of Human Genetics 1994, 54:966-974. http://www.ncbi.nlm.nih.gov/pubmed/8198140.
42. Inoue K., Ito S., Takai D., Soejima A., Shisa H., LePecq J.B., Segal-Bendirdjian E., Kagawa Y., Hayashi J.I. Isolation of mitochondrial DNAless mouse cell lines and their application for trapping mouse synaptosomal mitochondrial DNA with deletion mutations. Journal of Biological Chemistry 1997, 272:15510-15515. 10.1074/jbc.272.24.15510.
43. Trounce I., Schmiedel J., Yen H.C., Hosseini S., Brown M.D., Olson J.J., Wallace D.C. Cloning of neuronal mtDNA variants in cultured cells by synaptosome fusion with mtDNA-less cells. Nucleic Acids Research 2000, 28:2164-2170. http://www.ncbi.nlm.nih.gov/pubmed/10773087, 10.1093/nar/28.10.2164.
44. Ito S., Ohta S., Nishimaki K., Kagawa Y., Soma R., Kuno S.Y., Komatsuzaki Y., Mizusawa H., Hayashi J. Functional integrity of mitochondrial genomes in human platelets and autopsied brain tissues from elderly patients with Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:2099-2103. http://www.ncbi.nlm.nih.gov/pubmed/10051601, 10.1073/pnas.96.5.2099.
45. Chomyn A., Martinuzzi A., Yoneda M., Daga A., Hurko O., Johns D., Lai S.T., Nonaka I., Angelini C., Attardi G. MELAS mutation inmtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:4221-4225. http://www.ncbi.nlm.nih.gov/pubmed/1584755, 10.1073/pnas.89.10.4221.
46. King M.P., Koga Y., Davidson M., Schon E.A. Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Molecular and Cellular Biology 1992, 12:480-490. http://www.ncbi.nlm.nih.gov/pubmed/1732728.
47. Koga Y., Davidson M., Schon E.A., King M.P. Analysis of cybridsharboring MELAS mutations in the mitochondrial tRNA(Leu(UUR)) gene. Muscleand Nerve 1995, 3(Suppl.):S119-S123. http://www.ncbi.nlm.nih.gov/pubmed/7603512.
48. Shoubridge E.A. Segregation of mitochondrial DNAs carrying a pathogenic point mutation (tRNA(leu3243)) in cybrid cells. Biochemical and Biophysical Research Communications 1995, 213:189-195. http://www.ncbi.nlm.nih.gov/pubmed/7639735, 10.1006/bbrc.1995.2115.
49. Schon E.A., Koga Y., Davidson M., Moraes C.T., King M.P. The mitochondrial tRNA Leu(UUR) mutation in MELAS:a model for pathogenesis. Biochimica et Biophysica Acta 1992, 1101:206-208. 10.1016/0005-2728(92)90226-R10.1016/S0005-2728(05)80021-0.
50. Dunbar D.R., Moonie P.A., Jacobs H.T., Holt I.J. Different cellular backgrounds confer a marked advantage to either mutant or wild-type mitochondrial genomes. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:6562-6566. http://www.ncbi.nlm.nih.gov/pubmed/7604033, 10.1073/pnas.92.14.6562.
51. Chinnery P.F., Howell N., Lightowlers R.N., Turnbull D.M. Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes. Brain:A Journal of Neurology 1997, 120:1713-1721. http://www.ncbi.nlm.nih.gov/pubmed/9365365, 10.1093/brain/120.10.1713.
52. Chinnery P.F., Taylor D.J., Brown D.T., Manners D., Styles P., Lodi R. Very low levels of the mtDNA A3243G mutation associated with mitochondrial dysfunction in vivo. Annals of Neurology 2000, 47:381-384. http://www.ncbi.nlm.nih.gov/pubmed/10716261, 10.1002/1531-8249(200003)47:3<381::AID-ANA17>3.0.CO;2-2.
53. Yoneda M., Chomyn A., Martinuzzi A., Hurko O., Attardi G. Marked replicative advantage of human mtDNA carrying a point mutation that causes the MELAS encephalomyopathy. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:11164-11168. http://www.ncbi.nlm.nih.gov/pubmed/1454794, 10.1073/pnas.89.23.11164.
54. Turner C.J., Granycome C., Hurst R., Pohler E., Juhola M.K., Juhola M.I., Jacobs H.T., Sutherland L., Holt I.J. Systematic segregation to mutant mitochondrial DNA and accompanying loss of mitochondrial DNA in human NT2 teratocarcinoma cybrids. Genetics 2005, 170:1879-1885. http://www.ncbi.nlm.nih.gov/pubmed/15944344, 10.1534/genetics.105.043653.
55. Wallace D.C., Singh G., Lott M.T., Hodge J.A., Schurr T.G., Lezza A.M., Elsas L.J., Nikoskelainen E.K. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988, 242:1427-1430. http://www.ncbi.nlm.nih.gov/pubmed/3201231, 10.1126/science.3201231.
56. Johns D.R., Lessell S., Miller N.R. Molecularly confirmed Leber's hereditary optic neuropathy. Neurology 1991, 41:347.
57. Vergani L., Martinuzzi A., Carelli V., Cortelli P., Montagna P., Schievano G., Carrozzo R., Angelini C., Lugaresi E. MtDNA mutations associated with Leber's hereditary optic neuropathy: studies on cytoplasmic hybrid (cybrid) cells. Biochemical and Biophysical Research Communications 1995, 210:880-888. http://www.ncbi.nlm.nih.gov/pubmed/7763260, 10.1006/bbrc.1995.1740.
58. Hofhaus G., Johns D.R., Hurko O., Attardi G., Chomyn A. Respiration and growth defects in transmitochondrial cell lines carrying the 11778 mutation associated with Leber's hereditary optic neuropathy. Journal of Biological Chemistry 1996, 271:13155-13161. http://www.ncbi.nlm.nih.gov/pubmed/8662757, 10.1074/jbc.271.22.13155.
59. Cock H.R., Tabrizi S.J., Cooper J.M., Schapira A.H. The influence of nuclear background on the biochemical expression of 3460 Leber's hereditary optic neuropathy. Annals of Neurology 1998, 44:187-193. http://www.ncbi.nlm.nih.gov/pubmed/9708540, 10.1002/ana.410440208.
60. Brown M.D., Trounce I.A., Jun A.S., Allen J.C., Wallace D.C. Functional analysis of lymphoblast and cybrid mitochondria containing the 3460, 11778, or 14484 Leber's hereditary optic neuropathy mitochondrial DNA mutation. Journal of Biological Chemistry 2000, 275:39831-39836. http://www.ncbi.nlm.nih.gov/pubmed/10976107, 10.1074/jbc.M006476200.
61. Baracca A., Solaini G., Sgarbi G., Lenaz G., Baruzzi A., Schapira A.H.V., Martinuzzi A., Carelli V. Severe impairment of complex I-driven adenosine triphosphate synthesis in Leber hereditary optic neuropathy cybrids. Archives of Neurology 2005, 62:730-736. http://www.ncbi.nlm.nih.gov/pubmed/15883259, 10.1001/archneur.62.5.730.
62. Pello R., Martín M.A., Carelli V., Nijtmans L.G., Achilli A., Pala M., Torroni A., Gómez-Durán A., Ruiz-Pesini E., Martinuzzi A., Smeitink J.A., Arenas J., Ugalde C. Mitochondrial DNA background modulates the assembly kinetics of OXPHOS complexes in a cellular model of mitochondrial disease. Human Molecular Genetics 2008, 15:4001-4011.
63. Gómez-Durán A., Pacheu-Grau D., López-Gallardo E., Díez-Sánchez C., Montoya J., López-Pérez M.J., Ruiz-Pesini E. Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups. Human Molecular Genetics 2010, 19:3343-3353. http://www.ncbi.nlm.nih.gov/pubmed/20566709, 10.1093/hmg/ddq246.
64. Gómez-Durán A., Pacheu-Grau D., Martínez-Romero I., López-Gallardo E., López-Pérez M.J., Montoya J., Ruiz-Pesini E. Oxidative phosphorylation differences between mitochondrial DNA haplogroups modify the risk of Leber's hereditary optic neuropathy. Biochimica et Biophysica Acta 2012, 1822:1216-1222. http://www.ncbi.nlm.nih.gov/pubmed/22561905, 10.1016/j.bbadis.2012.04.014.
65. Pleasure S.J., Page C., Lee V.M.Y. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 1992, 12:1802-1815. http://www.ncbi.nlm.nih.gov/pubmed/1578271.
66. Schoeler S., Winkler-Stuck K., Szibor R., Haroon M.F., Gellerich F.N., Chamaon K., Mawrin C., Kirches E. Glutathione depletion in antioxidant defense of differentiated NT2-LHON cybrids. Neurobiology of Disease 2007, 25:536-544. http://www.ncbi.nlm.nih.gov/pubmed/17169568, 10.1016/j.nbd.2006.10.014.
67. Floreani M., Napoli E., Martinuzzi A., Pantano G., De Riva V., Trevisan R., Bisetto E., Valente L., Carelli V., Dabbeni-Sala F. Antioxidant defences in cybrids harboring mtDNA mutations associated with Leber's hereditary optic neuropathy. FEBS Journal 2005, 272:1124-1135. http://www.ncbi.nlm.nih.gov/pubmed/15720387, 10.1111/j.1742-4658.2004.04542.x.
68. Trounce I., Neill S., Wallace D.C. Cytoplasmic transfer of the mtDNA nt 8993 T→G (ATP6) point mutation associated with Leigh syndrome into mtDNA-less cells demonstrates cosegregation with a decrease in state III respiration and ADP/O ratio. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:8334-8338. http://www.ncbi.nlm.nih.gov/pubmed/8078883, 10.1073/pnas.91.18.8334.
69. Enriquez J.A., Chomyn A., Attardi G. MtDNA mutation in MERRF syndrome causes defective aminoacylation of tRNA(Lys) and premature translation termination. Nature Genetics 1995, 10:47-55. http://www.ncbi.nlm.nih.gov/pubmed/7647790, 10.1038/ng0595-47.
70. Masucci J.P., Davidson M., Koga Y., Schon E.A., King M.P. In vitro analysis of mutations causing myoclonus epilepsy with ragged-red fibers in the mitochondrial tRNA(Lys)gene: two genotypes produce similar phenotypes. Molecular and Cellular Biology 1995, 15:2872-2881. http://www.ncbi.nlm.nih.gov/pubmed/7739567.
71. Vergani L., Rossi R., Brierly C.H., Hanna M., Holt I.J. Introduction of heteroplasmic mitochondrial DNA (mtDNA) from a patient with NARP into two human q0 cell lines is associated with either selection and maintenance of NARP mutant mtDNA or failure to maintain mtDNA. Human Molecular Genetics 1999, 8:1751-1755. 10.1093/hmg/8.9.1751.
72. Tang Y., Schon E.A., Wilichowski E., Vazquez-Memije M.E., Davidson E., King M.P. Rearrangements of humanmitochondrialDNA (mtDNA): new insights into the regulation of mtDNA copy number and gene expression. Molecular Biology of the Cell 2000, 11:1471-1485. http://www.ncbi.nlm.nih.gov/pubmed/10749943, 10.1091/mbc.11.4.1471.
73. Palotti F., Baracca A., Hernandez-Rosa E., Walker W.F., Solaini G., Lenaz G., Melzi D'Eril G.V., DiMauro S., Schon E., Davidson M.M. Biochemical analysis of respiratory function in cybrid cell lines harbouring mitochondrial DNA mutations. Biochemical Journal 2004, 384:287-293. http://www.ncbi.nlm.nih.gov/pubmed/15324306, 10.1042/BJ20040561.
74. Kenyon L., Moraes C.T. Expanding the functional human mitochondrial DNA database by the establishment of primate xenomitochondrial cybrids. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:9131-9135. http://www.ncbi.nlm.nih.gov/pubmed/9256447, 10.1073/pnas.94.17.9131.
75. Barrientos A., Kenyon L., Moraes C.T. Human xenomitochondrial cybrids. Cellular models of mitochondrial complex I deficiency. Journal of Biological Chemistry 1998, 273:14210-14217. http://www.ncbi.nlm.nih.gov/pubmed/9603924, 10.1074/jbc.273.23.14210.
76. Swerdlow R.H. Mitochondrial DNA-related mitochondrial dysfunction in neurodegenerative diseases. Archives of Pathology and Laboratory Medicine 2002, 126:271-280.
77. Schwartz M., Vissing J. Paternal inheritance of mitochondrial DNA. New England Journal of Medicine 2002, 347:576-580. http://www.ncbi.nlm.nih.gov/pubmed/12192017, 10.1056/NEJMoa020350.
78. Swerdlow R.H., Parks J.K., Davis J.N., Cassarino D.S., Trimmer P.A., Currie L.J., Dougherty J., Bridges W.S., Bennett J.P., Wooten G.F., Parker W.D. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family. Annals of Neurology 1998, 44:873-881. 10.1002/ana.410440605.
79. Parker W.D., Swerdlow R.H. Mitochondrial dysfunction in idiopathic Parkinson disease. American Journal of Human Genetics 1998, 62:758-762. http://www.ncbi.nlm.nih.gov/pubmed/9529370, 10.1086/301812.
80. Brown D.T., Herbert M., Lamb V.K., Chinnery P.F., Taylor R.W., Lightowlers R.N., Craven L., Cree L., Gardner J.L., Turnbull D.M. Transmission of mitochondrial DNA disorders: possibilities for the future. Lancet 2006, 368:87-89. http://www.ncbi.nlm.nih.gov/pubmed/16815383, 10.1016/S0140-6736(06)68972-1.
81. Jakupciak J. New microarray improves sensitivity of cancer detection by pinpointing small changes in mitochondrial DNA. Affymetrix Microarray Bulletin 2005.
82. Jakupciak J.P., Wang W., Markowitz M.E., Ally D., Coble M., Srivastava S., Maitra A., Barker P.E., Sidransky D., O'Connell C.D. Mitochondrial DNA as a cancer biomarker. Journal of Molecular Diagnostics: JMD 2005, 7:258-267. http://www.ncbi.nlm.nih.gov/pubmed/15858150, 10.1016/S1525-1578(10)60553-3.
83. Michikawa Y., Mazzucchelli F., Bresolin N., Scarlato G., Attardi G. Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science 1999, 286:774-779. http://www.ncbi.nlm.nih.gov/pubmed/10531063, 10.1126/science.286.5440.774.
84. Coskun P.E., Beal M.F., Wallace D.C. Alzheimer's brains harbor somatic mtDNA control- region mutations that suppress mitochondrial transcription and replication. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:10726-10731. http://www.ncbi.nlm.nih.gov/pubmed/15247418, 10.1073/pnas.0403649101.
85. Parker W.D., Parks J.K. Mitochondrial ND5 mutations in idiopathic Parkinson's disease. Biochemical and Biophysical Research Communications 2005, 326:667-669. http://www.ncbi.nlm.nih.gov/pubmed/15596151, 10.1016/j.bbrc.2004.11.093.
86. Payne B.A., Wilson I.J., Yu-Wai-Man P., Coxhead J., Deehan D., Horvath R., Taylor R.W., Samuels D.C., Santibanez-Koref M., Chinnery P.F. Universal heteroplasmy of human mitochondrial DNA. Human Molecular Genetics 2013, 22:384-390. http://www.ncbi.nlm.nih.gov/pubmed/23077218, 10.1093/hmg/dds435.
87. Smigrodzki R.M., Khan S.M. Mitochondrial microheteroplasmy and a theory of aging and age-related disease. Rejuvenation Research 2005, 8:172-198. http://www.ncbi.nlm.nih.gov/pubmed/16144471, 10.1089/rej.2005.8.172.
88. Swerdlow R.H., Khan S.M. The Alzheimer's disease mitochondrial cascade hypothesis: an update. Experimental Neurology 2009, 218:308-315. http://www.ncbi.nlm.nih.gov/pubmed/19416677, 10.1016/j.expneurol.2009.01.011.
89. Parker W.D., Boyson S.J., Parks J.K. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Annals of Neurology 1989, 26:1231-1234. http://www.ncbi.nlm.nih.gov/pubmed/2557792.
90. Parker W.D., Filley C.M., Parks J.K. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 1990, 40:1302-1303. http://www.ncbi.nlm.nih.gov/pubmed/16637162166249, 10.1212/WNL.40.8.1302.
91. Swerdlow R.H. The neurodegenerative mitochondriopathies. Journal of Alzheimer's Disease 2009, 17:737-751. http://www.ncbi.nlm.nih.gov/pubmed/19542616.
92. Swerdlow R.H. Role of mitochondria in Parkinson's disease. Molecular Mechanisms of Neurodegenerative Diseases 2000, 233-270. Humana Press, Totowa, NJ. M.F. Chesselet (Ed.).
93. Swerdlow R.H., Kish S.J. Mitochondria in Alzheimer's disease. International Review of Neurobiology 2002, 53:341-385. 10.1016/S0074-7742(02)53013-0.
94. Swerdlow R.H. Mitochondria and cell bioenergetics: Increasingly recognized components and a possible etiologic cause of Alzheimer's disease. Antioxidants & Redox Signaling 2012, 16:1434-1455. http://www.ncbi.nlm.nih.gov/pubmed/21902597, 10.1089/ars.2011.4149.
95. Swerdlow R.H. Does mitochondrial DNA play a role in Parkinson's disease? A review of cybrid and other supportive evidence. Antioxidants & Redox Signaling 2012, 16:950-964. http://www.ncbi.nlm.nih.gov/pubmed/21338319, 10.1089/ars.2011.3948.
96. Parker W.D. Sporadic neurologic disease and the electron transport chain: A hypothesis. Proceedings of the 1989 Scientific Meeting of the American Society for Neurological Investigation: New Developments in Neuromuscular Disease 1990, Indiana University Printing Services, Bloomington, IN. R.M. Pascuzzi (Ed.).
97. Gu M., Cooper J.M., Taanman J.W., Schapira A.H. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease. Annals of Neurology 1998, 44:177-186. http://www.ncbi.nlm.nih.gov/pubmed/9708539, 10.1002/ana.410440207.
98. Shults C.W., Miller S.W. Reduced complex I activity in parkinsonian cybrids. Movement Disorders 1998, 13(Suppl.):S217.
99. Esteves A.R., Domingues A.F., Ferreira I.L., Januário C., Swerdlow R.H., Oliveira C.R., Cardoso S.M. Mitochondrial function in Parkinson's disease cybrids containing an nt2 neuron-like nuclear background. Mitochondrion 2008, 8:219-228. http://www.ncbi.nlm.nih.gov/pubmed/18495557, 10.1016/j.mito.2008.03.004.
100. Esteves A.R., Lu J., Rodova M., Onyango I., Lezi E., Dubinsky R., Lyons K.E., Pahwa R., Burns J.M., Cardoso S.M., Swerdlow R.H. Mitochondrial respiration and respiration-associated proteins in cell lines created through Parkinson's subject mitochondrial transfer. Journal of Neurochemistry 2010, 113:674-682. http://www.ncbi.nlm.nih.gov/pubmed/20132468, 10.1111/j.1471-4159.2010.06631.x.
101. Swerdlow R.H., Parks J.K., Cassarino D.S., Binder D.R., Bennett J.P., DiIorio G., Golbe L.I., Parker W.D. Biochemical analysis of cybrids expressing mitochondrial DNA from Contursi kindred Parkinson's subjects. Experimental Neurology 2001, 169:479-485. http://www.ncbi.nlm.nih.gov/pubmed/11358461, 10.1006/exnr.2001.7674.
102. Cassarino D.S., Fall C.P., Swerdlow R.H., Smith T.S., Halvorsen E.M., Miller S.W., Parks J.P., Parker W.D., Bennett J.P. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochimica et Biophysica Acta 1997, 1362:77-86. http://www.ncbi.nlm.nih.gov/pubmed/9434102, 10.1016/S0925-4439(97)00070-7.
103. 2-induced neuronal death. Neurobiology of Disease 2005, 20:141-154. http://www.ncbi.nlm.nih.gov/pubmed/16137575, 10.1016/j.nbd.2005.02.009.
104. Onyango I.G., Tuttle J.B., Bennett J.P. Activation of p38 and N-acetylcysteine-sensitive c-Jun NH2-terminal kinase signaling cascades is required for induction of apoptosis in Parkinson's disease cybrids. Molecular and Cellular Neuroscience 2005, 28:452-461. 10.1016/j.mcn.2004.10.006.
105. Cassarino D.S., Halvorsen E.M., Swerdlow R.H., Abramova N.N., Parker W.D., Sturgill T.W., Bennett J.P. Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-kappaB in cellular models of Parkinson's disease. Journal of Neurochemistry 2000, 74:1384-1392. http://www.ncbi.nlm.nih.gov/pubmed/10737593.
106. Veech G.A., Dennis J., Keeney P.M., Fall C.P., Swerdlow R.H., Parker W.D., Bennett J.P. Disrupted mitochondrial electron transport function increases expression of anti-apoptotic bcl-2 and bcl-X(L) proteins in SH-SY5Y neuroblastoma and in Parkinson disease cybrid cells through oxidative stress. Journal of Neuroscience Research 2000, 61:693-700. http://www.ncbi.nlm.nih.gov/pubmed/10972966, 10.1002/1097-4547(20000915)61:6<693::AID-JNR13>3.3.CO;2-W.
107. Sheehan J.P., Swerdlow R.H., Parker W.D., Miller S.W., Davis R.E., Tuttle J.B. Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease. Journal of Neurochemistry 1997, 68:1221-1233. http://www.ncbi.nlm.nih.gov/pubmed/9048769.
108. Trimmer P.A., Swerdlow R.H., Parks J.K., Keeney P., Bennett J.P., Miller S.W., Davis R.E., Parker W.D. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. Experimental Neurology 2000, 162:37-50. http://www.ncbi.nlm.nih.gov/pubmed/10716887, 10.1006/exnr.2000.7333.
109. Trimmer P.A., Borland M.K., Keeney P.M., Bennett J.P., Parker W.D. Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies. Journal of Neurochemistry 2004, 88:800-812. 10.1046/j.1471-4159.2003.02168.x.
110. Cronin-Furman E.N., Borland M.K., Bergquist K.E., Bennett J.P., Trimmer P.A. Mitochondrial quality, dynamics and functional capacity in Parkinson's disease cybrid cell lines selected for Lewybody expression. Molecular Neurodegeneration 2013, 26:6.
111. Aomi Y., Chen C.S., Nakada K., Ito S., Isobe K., Murakami H., Kuno S.Y., Tawata M., Matsuoka R., Mizusawa H., Hayashi J.I. Cytoplasmic transfer of platelet mtDNA from elderly patients with Parkinson's disease to mtDNA-less HeLa cells restores complete mitochondrial respiratory function. Biochemical and Biophysical Research Communications 2001, 280:265-273. http://www.ncbi.nlm.nih.gov/pubmed/11162509, 10.1006/bbrc.2000.4113.
112. Davis R.E., Miller S., Herrnstadt C., Ghosh S.S., Fahy E., Shinobu L.A., Galasko D., Thal L.J., Beal M.F., Howell N., Parker W.D. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:4526-4531. http://www.ncbi.nlm.nih.gov/pubmed/9114023, 10.1073/pnas.94.9.4526.
113. Davis R.E., Miller S., Herrnstadt C., Ghosh S.S., Fahy E., Shinobu L.A., Galasko D., Thal L.J., Beal M.F., Howell N., Parker W.D. Retraction. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:12069. http://www.ncbi.nlm.nih.gov/pubmed/165788579786782, 10.1073/pnas.95.20.12069-b.
114. Ghosh S.S., Swerdlow R.H., Miller S.W., Sheeman B., Parker W.D., Davis R.E. Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease. Annals of the New York Academy of Sciences 1999, 893:176-191. http://www.ncbi.nlm.nih.gov/pubmed/10672237, 10.1111/j.1749-6632.1999.tb07825.x.
115. Sheehan J.P., Swerdlow R.H., Miller S.W., Davis R.E., Parks J.K., Parker W.D., Tuttle J.B. Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 1997, 17:4612-4622. http://www.ncbi.nlm.nih.gov/pubmed/9169522.
116. Trimmer P.A., Keeney P.M., Borland M.K., Simon F.A., Almeida J., Swerdlow R.H., Parks J.P., Parker W.D., Bennett J.P. Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture. Neurobiology of Disease 2004, 15:29-39. http://www.ncbi.nlm.nih.gov/pubmed/14751768, 10.1016/j.nbd.2003.09.011.
117. Silva D.F., Santana I., Esteves A.R., Baldeiras I., Arduino D.M., Oliveira C.R., Cardoso S.M. Prodromal metabolic phenotype in MCI cybrids: implications for Alzheimer's disease. Current Alzheimer Research 2013, 10:180-190. http://www.ncbi.nlm.nih.gov/pubmed/22746213, 10.2174/1567205011310020008.
118. Cardoso S.M., Santana I., Swerdlow R.H., Oliveira C.R. Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity. Journal of Neurochemistry 2004, 89:1417-1426. http://www.ncbi.nlm.nih.gov/pubmed/15189344, 10.1111/j.1471-4159.2004.02438.x.
119. Khan S.M., Cassarino D.S., Abramova N.N., Keeney P.M., Borland M.K., Trimmer P.A., Krebs C.T., Bennett J.C., Parks J.K., Swerdlow R.H., Parker W.D., Bennett J.P. Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways. Annals of Neurology 2000, 48:148-155. http://www.ncbi.nlm.nih.gov/pubmed/10939564, 10.1002/1531-8249(200008)48:2<148::AID-ANA3>3.3.CO;2-Z.
120. Onyango I.G., Bennett J.P., Tuttle J.B. Endogenous oxidative stress in sporadic Alzheimer's disease neuronal cybrids reduces viability by increasing apoptosis through pro-death signaling pathways and is mimicked by oxidant exposure of control cybrids. Neurobiology of Disease 2005, 19:312-322. http://www.ncbi.nlm.nih.gov/pubmed/15837587, 10.1016/j.nbd.2005.01.026.
121. Onyango I.G., Tuttle J.B., Bennett J.P. Altered intracellular signaling and reduced viability of Alzheimer's disease neuronal cybrids is reproduced by beta-amyloid peptide acting through receptor for advanced glycation end products (RAGE). Molecular and Cellular Neurosciences 2005, 29:333-343. http://www.ncbi.nlm.nih.gov/pubmed/15911356, 10.1016/j.mcn.2005.02.012.
122. 2 and modulation by glutathione inhuman neuroblastoma and Alzheimer's disease cybrid cells. Brain Research. Molecular Brain Research 1999, 71:69-77. http://www.ncbi.nlm.nih.gov/pubmed/10407188, 10.1016/S0169-328X(99)00168-0.
123. De Sarno P., Bijur G.N., Lu R., Davis R.E., Jope R.S. Alterations in muscarinic receptor-coupled phosphoinositide hydrolysis and AP-1 activation in Alzheimer's disease cybrid cells. Neurobiology of Aging 2000, 21:31-38. http://www.ncbi.nlm.nih.gov/pubmed/10794846.
124. Cassarino D.S., Swerdlow R.H., Parks J.K., Parker W.D., Bennett J.P. Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of Alzheimer's disease cybrids. Biochemical and Biophysical Research Communications 1998, 248:168-173. http://www.ncbi.nlm.nih.gov/pubmed/9675105, 10.1006/bbrc.1998.8866.
125. +2 exchange are reduced in Alzheimer's disease cybrids. Mitochondrion 2005, 5:109-119. http://www.ncbi.nlm.nih.gov/pubmed/16050977, 10.1016/j.mito.2004.12.002.
126. Trimmer P.A., Borland M.K. Differentiated Alzheimer's disease transmitochondrial cybrid cell lines exhibit reduced organelle movement. Antioxidants & Redox Signaling 2005, 7:1101-1109. http://www.ncbi.nlm.nih.gov/pubmed/16115014, 10.1089/ars.2005.7.1101.
127. Silva D.F., Selfridge J.E., Lu J., E L., Roy N., Hutfles L., Burns J.M., Michaelis E.K., Yan S., Cardoso S.M., Swerdlow R.H. Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines. Human Molecular Genetics 2013, 1:3931-3943. http://www.ncbi.nlm.nih.gov/pubmed/23740939.
128. Gan X., Huang S., Wu L., Wang Y., Hu G., Li G., Zhang H., Yu H., Swerdlow R.H., Chen J.X., Yan S.S. Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer'sdisease cybrid cell. Biochimica et Biophysica Acta 2014, 1842:220-231. http://www.ncbi.nlm.nih.gov/pubmed/24252614, 10.1016/j.bbadis.2013.11.009.
129. Swerdlow R.H., Parks J.K., Cassarino D.S., Trimmer P.A., Miller S.W., Maguire D.J., Sheehan J.P., Maguire R.S., Pattee G., Juel V.C., Phillips L.H., Tuttle J.B., Bennett J.P., Davis R.E., Parker W.D. Mitochondrian sporadic amyotrophic lateral sclerosis. Experimental Neurology 1998, 153:135-142. 10.1006/exnr.1998.6866.
130. Swerdlow R.H., Parks J.K., Pattee G., Parker W.D. Role of mitochondria in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases 2000, 1:185-190. http://www.ncbi.nlm.nih.gov/pubmed/11464951, 10.1080/14660820050515179.
131. Swerdlow R.H., Parks J.K., Miller S.W., Pattee G., Davis R.E., Parker W.D. Evidence of genetic mitochondrial pathology in sporadic amyotrophic lateral sclerosis. Society for Neuroscience Abstracts 1996, 22:2143.
132. Wiedemann F.R., Winkler K., Kuznetsov A.V., Bartels C., Vielhaver S., Feistner H., Kunz W.S. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences 1998, 156:65-72. http://www.ncbi.nlm.nih.gov/pubmed/9559989, 10.1016/S0022-510X(98)00008-2.
133. Gajewski C.D., Lin M.T., Cudkowicz M.E., Beal M.F., Manfredi G. Mitochondrial DNA from platelets of sporadic ALS patients restores normal respiratory functions in rho(0) cells. Experimental Neurology 2003, 179:229-235. http://www.ncbi.nlm.nih.gov/pubmed/12618129, 10.1016/S0014-4886(02)00022-5.
134. Di Monte D.A., Harati Y., Jankovic J., Sandy M.S., Jewell S.A., Langston J.W. Muscle mitochondrial ATP production in progressive supranuclear palsy. Journal of Neurochemistry 1994, 62:1631-1634. http://www.ncbi.nlm.nih.gov/pubmed/8133289.
135. Swerdlow R.H., Golbe L.I., Parks J.K., Cassarino D.S., Binder D.R., Grawey A.E., Litvan I., Bennett J.P., Wooten G.F., Parker W.D. Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy. Journal of Neurochemistry 2000, 75:1681-1684. http://www.ncbi.nlm.nih.gov/pubmed/10987850.
136. Albers D.S., Swerdlow R.H., Manfredi G., Gajewski C., Yang L., Parker W.D., Beal M.F. Further evidence for mitochondrial dysfunction in progressive supranuclear palsy. Experimental Neurology 2001, 168:196-198. http://www.ncbi.nlm.nih.gov/pubmed/11170735, 10.1006/exnr.2000.7607.
137. Chirichigno J.W., Manfredi G., Beal M.F., Albers D.S. Stress-induced mitochondrial depolarization and oxidative damage in PSP cybrids. Brain Research 2002, 951:31-35. http://www.ncbi.nlm.nih.gov/pubmed/12231453, 10.1016/S0006-8993(02)03101-3.
138. Swerdlow R.H., Parks J.K., Cassarino D.S., Shilling A.T., Bennett J.P., Harrison M.B., Parker W.D. Characterization of cybrid cell lines containing mtDNA from Huntington's disease patients. Biochemical and Biophysical Research Communications 1999, 261:701-704. http://www.ncbi.nlm.nih.gov/pubmed/10441489.
139. Parker W.D., Boyson S.J., Luder A.S., Parks J.K. Evidence for a defect in NADH: Ubiquinone oxidoreductase (complex I) in Huntington's disease. Neurology 1990, 40:1231-1234. http://www.ncbi.nlm.nih.gov/pubmed/2143271, 10.1212/WNL.40.8.1231.
140. Ferreira I.L., Nascimento M.V., Ribeiro M., Almeida S., Cardoso S.M., Grazina M., Pratas J., Santos M.J., Januário C., Oliveira C.R., Rego A.C. Mitochondrial-dependent apoptosis in Huntington's disease human cybrids. Experimental Neurology 2010, 222:243-255. http://www.ncbi.nlm.nih.gov/pubmed/20079354, 10.1016/j.expneurol.2010.01.002.
141. Ferreira I.L., Cunha-Oliveira T., Nascimento M.V., Ribeiro M., Proença M.T., Januário C., Oliveira C.R., Rego A.C. Bioenergetic dysfunction in Huntington's disease human cybrids. Experimental Neurology 2011, 23:127-134. http://www.ncbi.nlm.nih.gov/pubmed/21684277.
142. Laderman K.A., Penny J.R., Mazzucchelli F., Bresolin N., Scarlato G., Attardi G. Aging-dependent functional alterations of mitochondrial DNA (mtDNA) from human fibroblasts transferred into mtDNA-less cells. Journal of Biological Chemistry 1996, 271:15891-15897. http://www.ncbi.nlm.nih.gov/pubmed/8663253, 10.1074/jbc.271.27.15891.
143. Hayashi J., Ohta S., Kagawa Y., Kondo H., Kaneda H., Yonekawa H., Takai D., Miyabayashi S. Nuclear but not mitochondrial genome involvement in human age-related mitochondrial dysfunction. Functional integrity of mitochondrial DNA from aged subjects. Journal of Biological Chemistry 1994, 269:6878-6883. http://www.ncbi.nlm.nih.gov/pubmed/8120050.
144. Seibel P., Di Nunno C., Kukat C., Schäfer I., Del Bo R., Bordoni A., Comi G.P., Schön A., Capuano F., Latorre D., Villani G. Cosegregation of novel 16S rRNA gene mutations with the age-associated T414G variant in human cybrids. Nucleic Acids Research 2008, 36:5872-5881. http://www.ncbi.nlm.nih.gov/pubmed/18796524, 10.1093/nar/gkn592.
145. Hao H., Morrison L.E., Moraes C.T. Suppression of a mitochondrial tRNA gene mutation phenotype associated with changes in the nuclear background. Human Molecular Genetics 1999, 8:1117-1124. http://www.ncbi.nlm.nih.gov/pubmed/10332045, 10.1093/hmg/8.6.1117.
146. Deng J.H., Li Y., Park J.S., Wu J., Hu P., Lechleiter J., Bai Y. Nuclear suppression of mitochondrial defects in cells without the ND6 subunit. Molecular and Cellular Biology 2006, 26:1077-1086. http://www.ncbi.nlm.nih.gov/pubmed/16428459, 10.1128/MCB.26.3.1077-1086.2006.
147. Kunz W.S. Different metabolic properties of mitochondrial oxidative phosphorylation in different cell types-important implications for mitochondrial cytopathies. Experimental Physiology 2003, 88:149-154. http://www.ncbi.nlm.nih.gov/pubmed/12525863, 10.1113/eph8802512.
148. Johnson D.T., Harris R.A., French S., Blair P.V., You J., Bemis K., Wang M., Balaban R.S. The tissue heterogeneity of the mammalian mitochondrial proteome. American Journal of Physiology Cell Physiology 2006, 292:C689-C697.
149. Saksela E. Variation of the chromosome number and anomalous mitoses in HeLa cells. Acta Pathologica et Microbiologica Scandinavica 1962, 154(Suppl.):156-159. http://www.ncbi.nlm.nih.gov/pubmed/14496227.
150. Andrews P.W., Damjanov I., Simon D., Banting G.S., Carlin C., Dracopoli N.C., Fogh J. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Laboratory Investigation; a Journal of Technical Methods and Pathology 1984, 50:147-162. http://www.ncbi.nlm.nih.gov/pubmed/6694356.
151. Kim G.J., Park S.Y., Kim H., Chun Y.H., Park S.H. Chromosomal aberrations in neuroblastoma cell lines identified by cross species color banding and chromosome painting. Cancer Genetics and Cytogenetics 2001, 129:10-16. http://www.ncbi.nlm.nih.gov/pubmed/11520559, 10.1016/S0165-4608(01)00418-6.
152. Nelson P.T., Kondziolka D., Wechsler L., Goldstein S., Gebel J., DeCesare S., Elder E.M., Zhang P.J., Jacobs A., McGrogan M., Lee V.M.Y., Trojanowski J.Q. Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation. American Journal of Pathology 2002, 160:1201-1206. http://www.ncbi.nlm.nih.gov/pubmed/11943704, 10.1016/S0002-9440(10)62546-1.
153. Cohen N., Betts D.R., Rechavi G., Amariglio N., Trakhtenbrot L. Clonal expansion and not cell interconversion is the basis for the neuroblast and non neuronal types of the SK-N-SH neuroblastoma cell line. Cancer Genetics and Cytogenetics 2003, 143:8-84.
154. Moreno-Loshuertos R., Acin-Perez R., Fernandez-Silva P., Movilla N., Perez-Martos A., de Cordoba S.R., Gallardo M.E., Enriquez J.A. Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants. Nature Genetics 2006, 38:1261-1268. http://www.ncbi.nlm.nih.gov/pubmed/17013393, 10.1038/ng1897.
155. Roubertoux P.L., Sluyter F., Carlier M., Marcet B., Maarouf-Veray F., Cherif C., Marican C., Arrechi P., Godin F., Jamon M., Verrier B., Cohen-Salmon C. Mitochondrial DNA modifies cognition in interaction with the nuclear genome and age in mice. Nature Genetics 2003, 35:65-69. http://www.ncbi.nlm.nih.gov/pubmed/12923532, 10.1038/ng1230.
156. Yu X., Gimsa U., Wester-Rosenlöf L., Kanitz E., Otten W., Kunz M., Ibrahim S.M. Dissecting the effects of mtDNA variations on complex traits using mouse conplastic strains. Genome Research 2009, 19:159-165. http://www.ncbi.nlm.nih.gov/pubmed/19037013.
157. Yu X., Wester-Rosenlöf L., Gimsa U., Holzhueter S.A., Marques A., Jonas L., Hagenow K., Kunz M., Nizze H., Tiedge M., Holmdahl R., Ibrahim S.M. The mtDNA nt7778 G/T polymorphism affects autoimmune diseases and reproductive performance in the mouse. Human Molecular Genetics 2009, 18:4689-4698. http://www.ncbi.nlm.nih.gov/pubmed/19759059, 10.1093/hmg/ddp432.
158. Pravenec M., Hyakukoku M., Houstek J., Zidek V., Landa V., Mlejnek P., Miksik I., Dudová-Mothejzikova K., Pecina P., Vrbacky M., Drahota Z., Vojtiskova A., Mracek T., Kazdova L., Oliyarnyk O., Wang J., Ho C., Qi N., Sugimoto K., Kurtz T. Direct linkage of mitochondrial genome variation to risk factors for type 2 diabetes in conplastic strains. Genome Research 2007, 17:1319-1326. http://www.ncbi.nlm.nih.gov/pubmed/17693571, 10.1101/gr.6548207.
159. Mott J.L., Zhang D., Farrar P.L., Chang S.W., Zassenhaus H.P. Low frequencies of mitochondrial DNA mutations cause cardiac disease in the mouse. Annals of the New York Academy of Sciences 1999, 893:353-357. http://www.ncbi.nlm.nih.gov/pubmed/10672265.
160. Trifunovic A., Wredenberg A., Falkenberg M., Spelbrink J.N., Rovio A.T., Bruder C.E., Bohlooly Y., Gidlof S., Oldfors A., Wibom R., Tornell J., Jacobs H.T., Larsson N.G. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 2004, 429:417-423. http://www.ncbi.nlm.nih.gov/pubmed/15164064, 10.1038/nature02517.
161. Kujoth G.C., Hiona A., Pugh T.D., Someya S., Panzer K., Wohlgemuth S.E., Hofer T., Seo A.Y., Sullivan R., Jobling W.A., Morrow J.D., Van Remmen H., Sedivy J.M., Yamasoba T., Tanokura M., Weindruch R., Leeuwenburgh C., Prolla T.A. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 2005, 309:481-484. http://www.ncbi.nlm.nih.gov/pubmed/16020738, 10.1126/science.1112125.
162. Pinkert C.A., Trounce I.A. Production of transmitochondrial mice. Methods 2002, 26:348-357. http://www.ncbi.nlm.nih.gov/pubmed/12054926, 10.1016/S1046-2023(02)00041-5.
163. McKenzie M., Trounce I.A., Cassar C.A., Pinkert C.A. Production of homoplasmic xenomitochondrial mice. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:1685-1690. http://www.ncbi.nlm.nih.gov/pubmed/14745024, 10.1073/pnas.0303184101.
164. Khan S.M., Smigrodzki R.M., Swerdlow R. Cell and animal models of mtDNA biology: progress and prospects. American Journal of Physiology. Cell Physiology 2007, [Epub ahead of print]. http://www.ncbi.nlm.nih.gov/pubmed/16899549.
165. Wang Y., Pan Y., Price A., Martin L.J. Generation and characterization of transgenic mice expressing mitochondrial targeted red fluorescent protein selectively in neurons: Modeling mitochondriopathy in excitotoxicity and amyotrophic lateral sclerosis. Molecular Neurodegeneration 2011, 2:75. http://www.ncbi.nlm.nih.gov/pubmed/22047141.
166. Fetterman J.L., Zelickson B.R., Johnson L.W., Moellering D.R., Westbrook D.G., Pompilius M., Sammy M.J., Johnson M., Dunham-Snary K.J., Cao X., Bradley W.E., Zhang J., Wei C.C., Chacko B., Schurr T.G., Kesterson R.A., Dell'Italia L.J., Darley-Usmar V.M., Welch D.R., Ballinger S.W. Mitochondrial genetic background modulates bioenergetics and susceptibility to acute cardiac volume overload. Biochemical Journal 2013, 455:157-167. http://www.ncbi.nlm.nih.gov/pubmed/23924350, 10.1042/BJ20130029.